A bispecific nanobody hitting primary endpoints in both asthma and CRSwNP phase 2 trials isn't just a pipeline win...

At BIO-Europe Spring 2026, leaders from Eli Lilly, Schrödinger, Boltz, Bioptimus, and Sofinnova Partners convened to diagnose how foundation...

At the BIO-Europe Spring 2026 conference in Lisbon, a distinguished panel of business development and finance leaders convened to...

Seven biopharma deals worth $29 billion closed in the final two weeks of March 2026. The street called it...

CAMP4 Therapeutics has appointed Michael MacLean to its board of directors as the company readies CMP-002, an antisense oligonucleotide...

Serina Therapeutics has opened a Phase 1b clinical trial of SER-252, a subcutaneous apomorphine candidate built on the company’s...

Exicure reported 2025 results that underscore a high-stakes pivot and an urgent need for capital. Cash fell to $3.7...

Kura Oncology has granted inducement stock options to six new employees, covering 153,750 shares at an exercise price of...

Syndax Pharmaceuticals has granted inducement stock options for up to 228,500 shares to eight new employees under its 2023...

A plant-derived compound with a novel mechanism, eight weeks of effect from three days of dosing, and a Phase...